ALEXION PHARMACEUTICALS
Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2... 009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.
ALEXION PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1992-01-01
Address:
Cheshire, Connecticut, United States
Country:
United States
Website Url:
http://www.alexion.com
Total Employee:
1001+
Status:
Active
Contact:
(203) 272-2596
Email Addresses:
[email protected]
Total Funding:
5.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving SSL By Default Google Tag Manager Apple Mobile Web Clips Icon Google Font API HSTS LetsEncrypt Mobile Non Scaleable Content
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Connetics
Connetics Corporation engages in the development and commercialization of products for the medical dermatology market.
Mallinckrodt
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Merz Pharma
Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.
Quinnova Pharmaceuticals
Quinnova Pharmaceuticals is a biotech company engaged in the development and commercialization of prescription drug products.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-10-03 | LogicBio Therapeutics | LogicBio Therapeutics acquired by Alexion Pharmaceuticals | 70 M USD |
| 2020-05-05 | Portola Pharmaceuticals | Portola Pharmaceuticals acquired by Alexion Pharmaceuticals | 1.4 B USD |
| 2019-10-16 | Achillion Pharmaceuticals | Achillion Pharmaceuticals acquired by Alexion Pharmaceuticals | N/A |
| 2018-09-26 | Syntimmune | Syntimmune acquired by Alexion Pharmaceuticals | 1.2 B USD |
| 2018-04-11 | Wilson Therapeutics | Wilson Therapeutics acquired by Alexion Pharmaceuticals | N/A |
| 2015-05-06 | Synageva BioPharma | Synageva BioPharma acquired by Alexion Pharmaceuticals | 8.4 B USD |
| 2011-12-29 | Enobia Pharma | Enobia Pharma acquired by Alexion Pharmaceuticals | N/A |
| 2011-01-31 | Taligen Therapeutics | Taligen Therapeutics acquired by Alexion Pharmaceuticals | 111 M USD |
| 2000-09-25 | Prolifaron | Prolifaron acquired by Alexion Pharmaceuticals | 41 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-01-05 | Moderna | Alexion Pharmaceuticals investment in Series E - Moderna | 450 M USD |
| 2014-01-14 | Moderna | Alexion Pharmaceuticals investment in Corporate Round - Moderna | 25 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-06 | Alexion hires first chief diversity officer, following pharma peers and social sentiment |
| 2020-02-04 | Amylyx Pharmaceuticals Appoints Jeffrey Trigilio Chief Financial Officer |
Official Site Inspections
http://www.alexion.com Semrush global rank: 530.26 K Semrush visits lastest month: 64.27 K
- Host name: server-18-67-65-8.iad89.r.cloudfront.net
- IP address: 18.67.65.8
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alexion Pharmaceuticals"
Leadership | Alexion Global Site
Our management team is a talented, diverse, and experienced group of leaders who bring vast expertise across every aspect of our business and operations and a commitment to advance …See details»
Alexion Global Site
Alexion’s leadership in rare disease is driven by the many individuals whose expertise, creativity and tenacity fuel our commitment to advancing innovative science. View All News Veeva ID: …See details»
Alexion Pharmaceuticals - Wikipedia
Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell, a physician at Yale New Haven Hospital and assistant …See details»
Org Chart Alexion Pharmaceuticals - The Official Board
The organizational chart of Alexion Pharmaceuticals displays its 47 main executives including Marc Dunoyer, Sean Christie and Shane Doyle. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. …See details»
About Us - Alexion
By creating an unparalleled employee experience, our organization is equipped to adapt to and enrich employees with a productive, engaging, and enjoyable work experience while …See details»
International Recruitment - Find Employees - Hire …
Alexion Global Talents is a division of Alexion Management Partners GmbH, an International Management Consulting Services firm headquartered in Berlin, Germany. Focussing on solving our clients’ challenging business issues with a …See details»
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the ...See details»
Locations - Alexion
Alexion has more than 5,000 employees around the globe and serves patients in more than 50 countries. There are limitless opportunities for talented individuals to work across functions and geographies, taking on new challenges to …See details»
Our Approach | Alexion Global Site
Alexion’s rich history of scientific firsts has accelerated the course of rare disease R&D and changed the trajectory of treatment for people living with certain rare conditions. We are driven by a sense of urgency to push the boundaries of …See details»
Clinical Development and Medical Affairs - The Org
The Clinical Development and Medical Affairs team at Alexion Pharmaceuticals is responsible for the strategic planning and execution of clinical trials to evaluate new biologic therapies for life …See details»
About Us | Alexion US Site
As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases. Our Mission To transform the lives of people affected by rare diseases and …See details»
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients …See details»
Working at Alexion
Life at Alexion. At Alexion, we foster an environment that attracts and retains the best talent. We provide the tools to enable each individual to perform at their personal best so that we …See details»
Alexion Pharmaceuticals - Leadership Team - The Org
The Leadership Team at Alexion Pharmaceuticals is responsible for setting the strategic direction of the company, overseeing operational execution across v. ... and maintain regulatory …See details»
Alexion
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. MAKING A MEANINGFUL IMPACT FOR PEOPLE LIVING …See details»
Alexion data presented at the 2025 AAN Annual Meeting highlight ...
17 hours ago Alexion, AstraZeneca Rare Disease is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and …See details»
About Us - careers.alexion.com
Life at Alexion. At Alexion, we foster an environment that attracts and retains the best talent. We provide the tools to enable each individual to perform at their personal best so that we …See details»
Alexion Charitable Foundation | Alexion Global Site
The Alexion Charitable Foundation (ACF) is designed to have the most positive impact possible on the communities we serve. Our mission is to address the health disparities within and …See details»
Director, Country Operations Management at Alexion
Feb 14, 2025 Proactively connecting with other Country leaders to share issues and learnings to ensure overall success of COM organization Managing TA-level internal and external …See details»
Iptacopan in paroxysmal nocturnal haemoglobinuria: a profile of …
2 days ago Iptacopan (Fabhalta®), a complement factor B inhibitor, is a valuable treatment option for adult patients with paroxysmal nocturnal haemoglobinuria (PNH). It is the first oral …See details»